Published in Clin Infect Dis on July 08, 2002
Central nervous system tuberculosis: pathogenesis and clinical aspects. Clin Microbiol Rev (2008) 2.88
Comparison of conventional bacteriology with nucleic acid amplification (amplified mycobacterium direct test) for diagnosis of tuberculous meningitis before and after inception of antituberculosis chemotherapy. J Clin Microbiol (2004) 1.64
Diagnosis of central nervous system tuberculosis by T-cell-based assays on peripheral blood and cerebrospinal fluid mononuclear cells. Clin Vaccine Immunol (2008) 1.11
Evaluation of a modified gen-probe amplified direct test for detection of Mycobacterium tuberculosis complex organisms in cerebrospinal fluid. J Clin Microbiol (2004) 0.96
Evaluation of the IS6110 PCR assay for the rapid diagnosis of tuberculous meningitis. Cerebrospinal Fluid Res (2007) 0.91
Filtration of cerebrospinal fluid improves isolation of mycobacteria. J Clin Microbiol (2008) 0.79
Practice guidelines for outpatient parenteral antimicrobial therapy. IDSA guidelines. Clin Infect Dis (2004) 3.35
Central nervous system tuberculosis: pathogenesis and clinical aspects. Clin Microbiol Rev (2008) 2.88
Role of microglia in central nervous system infections. Clin Microbiol Rev (2004) 2.69
Comparison of 2 blood culture media shows significant differences in bacterial recovery for patients on antimicrobial therapy. Clin Infect Dis (2012) 2.47
Diagnostic performance of rapid diagnostic tests versus blood smears for malaria in US clinical practice. Clin Infect Dis (2009) 1.91
Morphine induces apoptosis of human microglia and neurons. Neuropharmacology (2002) 1.61
Strongyloides hyperinfection presenting as acute respiratory failure and gram-negative sepsis. Chest (2005) 1.57
Dyssynchrony indices to predict response to cardiac resynchronization therapy: a comprehensive prospective single-center study. Circ Heart Fail (2010) 1.52
Globalization: a new dimension for academic internal medicine. Am J Med (2006) 1.50
Synthetic cannabinoid WIN55,212-2 inhibits generation of inflammatory mediators by IL-1beta-stimulated human astrocytes. Glia (2005) 1.49
Opioid G protein-coupled receptors: signals at the crossroads of inflammation. Trends Immunol (2003) 1.45
Toll-like receptors in defense and damage of the central nervous system. J Neuroimmune Pharmacol (2007) 1.24
Microglia as a pharmacological target in infectious and inflammatory diseases of the brain. J Neuroimmune Pharmacol (2006) 1.23
Evaluation of malaria screening in newly arrived refugees to the United States by microscopy and rapid antigen capture enzyme assay. Pediatr Infect Dis J (2006) 1.21
Morphine potentiates HIV-1 gp120-induced neuronal apoptosis. J Infect Dis (2005) 1.20
Differential responses of human brain cells to West Nile virus infection. J Neurovirol (2005) 1.17
Mycobacterium tuberculosis-induced cytokine and chemokine expression by human microglia and astrocytes: effects of dexamethasone. J Infect Dis (2005) 1.17
TNF-alpha-induced chemokine production and apoptosis in human neural precursor cells. J Leukoc Biol (2005) 1.14
High-level expression of functional chemokine receptor CXCR4 on human neural precursor cells. Brain Res Dev Brain Res (2004) 1.09
Cocaine-induced HIV-1 expression in microglia involves sigma-1 receptors and transforming growth factor-beta1. Int Immunopharmacol (2006) 1.08
CXCL10 production from cytomegalovirus-stimulated microglia is regulated by both human and viral interleukin-10. J Virol (2003) 1.08
Neural precursor cell susceptibility to human cytomegalovirus diverges along glial or neuronal differentiation pathways. J Neurosci Res (2005) 1.07
Serial testing of refugees for latent tuberculosis using the QuantiFERON-gold in-tube: effects of an antecedent tuberculin skin test. Am J Trop Med Hyg (2009) 1.03
Cocaine alters proliferation, migration, and differentiation of human fetal brain-derived neural precursor cells. J Pharmacol Exp Ther (2006) 1.01
Antimicrobial resistance in Escherichia coli causing urinary tract infections in Costa Rica: a clinical dilemma. Int J Antimicrob Agents (2003) 0.98
WIN55,212-2-mediated inhibition of HIV-1 expression in microglial cells: involvement of cannabinoid receptors. J Neuroimmune Pharmacol (2006) 0.96
Extrapulmonary Tuberculosis among Somalis in Minnesota. Emerg Infect Dis (2006) 0.95
Viral pathogens in acute exacerbations of chronic obstructive pulmonary disease. Intern Emerg Med (2008) 0.95
Aortic root replacement with a novel decellularized cryopreserved aortic homograft: postoperative immunoreactivity and early results. J Thorac Cardiovasc Surg (2005) 0.95
U50,488 inhibits HIV-1 Tat-induced monocyte chemoattractant protein-1 (CCL2) production by human astrocytes. Biochem Pharmacol (2003) 0.93
The association of septic thrombophlebitis with septic pulmonary embolism in adults. Open Respir Med J (2012) 0.93
Morphine stimulates CCL2 production by human neurons. J Neuroinflammation (2006) 0.92
Financial implications of refugee malaria: the impact of pre-departure presumptive treatment with anti-malarial drugs. Am J Trop Med Hyg (2007) 0.92
Short communication: Transmitted drug resistance and molecular epidemiology in antiretroviral naive HIV type 1-infected patients in Rhode Island. AIDS Res Hum Retroviruses (2010) 0.92
Kappa-opioid receptor agonist inhibition of HIV-1 envelope glycoprotein-mediated membrane fusion and CXCR4 expression on CD4(+) lymphocytes. Biochem Pharmacol (2002) 0.90
The potential of brain natriuretic peptide as a biomarker for New York Heart Association class during the outpatient treatment of heart failure. J Card Fail (2002) 0.90
Glial cell responses to herpesvirus infections: role in defense and immunopathogenesis. J Infect Dis (2002) 0.90
Carvedilol therapy is associated with a sustained decline in brain natriuretic peptide levels in patients with congestive heart failure. Am Heart J (2005) 0.90
Kappa-opioid receptor ligands inhibit cocaine-induced HIV-1 expression in microglial cells. J Pharmacol Exp Ther (2004) 0.88
Anti-HIV-1 activity of propolis in CD4(+) lymphocyte and microglial cell cultures. J Ethnopharmacol (2005) 0.88
Potentiation of HIV-1 expression in microglial cells by nicotine: involvement of transforming growth factor-beta 1. J Neuroimmune Pharmacol (2007) 0.87
Preferential sensitivity of human dopaminergic neurons to gp120-induced oxidative damage. J Neurovirol (2009) 0.86
Morphine modulates gammadelta lymphocytes cytolytic activity following BCG vaccination. Brain Behav Immun (2006) 0.82
Nucleic-acid amplification testing of urine vs. patient complaint-driven evaluation. J Emerg Med (2008) 0.80
Role of nitric oxide in defense of the central nervous system against Mycobacterium tuberculosis. J Infect Dis (2008) 0.79
Long-term outcome and the use of revascularization in patients with heart failure, suspected ischemic heart disease, and large reversible myocardial perfusion defects. Am Heart J (2002) 0.77
Relationship of myocardial perfusion imaging findings to outcome of patients with heart failure and suspected ischemic heart disease. Am Heart J (2004) 0.76
Human neural precursor cells express functional kappa-opioid receptors. J Pharmacol Exp Ther (2007) 0.76
Changes in the NMR metabolic profile of human microglial cells exposed to lipopolysaccharide or morphine. J Neuroimmune Pharmacol (2010) 0.76
Use of sequence data generated in the Bayer Tru Gene genotyping assay to recognize and characterize non-subtype-b human immunodeficiency virus type 1 strains. J Clin Microbiol (2005) 0.75
Detection of fluconazole-resistant isolates of Candida glabrata by using an agar screen assay. J Clin Microbiol (2003) 0.75
Loa loa presenting in a ThinPrep Pap test: case report and review of parasites in cervicovaginal cytology specimens. Diagn Cytopathol (2003) 0.75
Fungal conidiospores in a peritoneal fluid gram stain. Arch Pathol Lab Med (2005) 0.75
A study of results generated using the Abbott LCx-GC assay fails to reveal a performance-based rationale for the 2002 level 1 recall. Am J Clin Pathol (2005) 0.75
Ten Rules for Antibiotic Prescribing. Minn Med (2016) 0.75
Comparison of selective and nonselective enrichment broth media for the detection of vaginal and anorectal colonization with group B streptococcus. Diagn Microbiol Infect Dis (2005) 0.75
Urinary tract infection. Postgrad Med (1996) 0.75